ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 177 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,069,177 | +1586.4% | 149,789 | +1210.4% | 0.01% | +1100.0% |
| Q3 2022 | $182,000 | +4.0% | 11,431 | -10.2% | 0.00% | 0.0% |
| Q2 2022 | $175,000 | -12.1% | 12,731 | +1.4% | 0.00% | 0.0% |
| Q1 2022 | $199,000 | -24.9% | 12,551 | +3.3% | 0.00% | 0.0% |
| Q4 2021 | $265,000 | -27.6% | 12,151 | -0.8% | 0.00% | 0.0% |
| Q3 2021 | $366,000 | -34.4% | 12,251 | -2.8% | 0.00% | -50.0% |
| Q2 2021 | $558,000 | -13.4% | 12,601 | -13.1% | 0.00% | 0.0% |
| Q1 2021 | $644,000 | -36.7% | 14,506 | -21.9% | 0.00% | -50.0% |
| Q4 2020 | $1,018,000 | +14.1% | 18,566 | -52.4% | 0.00% | 0.0% |
| Q3 2020 | $892,000 | +9.9% | 39,004 | +0.6% | 0.00% | 0.0% |
| Q2 2020 | $812,000 | +66.4% | 38,783 | +10.8% | 0.00% | +33.3% |
| Q1 2020 | $488,000 | -75.3% | 34,992 | -59.8% | 0.00% | -70.0% |
| Q4 2019 | $1,979,000 | – | 86,957 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 16,037,486 | $280,250,000 | 19.13% |
| TANG CAPITAL MANAGEMENT LLC | 2,965,485 | $52,015,000 | 9.58% |
| Boxer Capital, LLC | 1,466,051 | $25,715,000 | 2.97% |
| Ghost Tree Capital, LLC | 600,000 | $10,524,000 | 2.75% |
| BRIDGER MANAGEMENT, LLC | 1,529,032 | $26,819,000 | 2.12% |
| Cormorant Asset Management, LP | 1,700,000 | $29,818,000 | 2.02% |
| EcoR1 Capital, LLC | 450,000 | $7,893,000 | 0.73% |
| UNIVERSITY OF NOTRE DAME DU LAC | 171,015 | $3,000,000 | 0.67% |
| Virtus ETF Advisers LLC | 17,799 | $312,000 | 0.66% |
| SPHERA FUNDS MANAGEMENT LTD. | 290,001 | $5,087,000 | 0.46% |